Efferocytosis of dying cells differentially modulate immunological outcomes in tumor microenvironment

Sushil Kumar, David Calianese, Raymond Birge

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

Programmed cell death (apoptosis) is an integral part of tissue homeostasis in complex organisms, allowing for tissue turnover, repair, and renewal while simultaneously inhibiting the release of self antigens and danger signals from apoptotic cell-derived constituents that can result in immune activation, inflammation, and autoimmunity. Unlike cells in culture, the physiological fate of cells that die by apoptosis in vivo is their rapid recognition and engulfment by phagocytic cells (a process called efferocytosis). To this end, apoptotic cells express specific eat-me signals, such as externalized phosphatidylserine (PS), that are recognized in a specific context by receptors to initiate signaling pathways for engulfment. The importance of carefully regulated recognition and clearance pathways is evident in the spectrum of inflammatory and autoimmune disorders caused by defects in PS receptors and signaling molecules. However, in recent years, several additional cell death pathways have emerged, including immunogenic cell death, necroptosis, pyroptosis, and netosis that interweave different cell death pathways with distinct innate and adaptive responses from classical apoptosis that can shape long-term host immunity. In this review, we discuss the role of different cell death pathways in terms of their immune potential outcomes specifically resulting in specific cell corpse/phagocyte interactions (phagocytic synapses) that impinge on host immunity, with a main emphasis on tolerance and cancer immunotherapy.

Original languageEnglish (US)
Pages (from-to)149-164
Number of pages16
JournalImmunological Reviews
Volume280
Issue number1
DOIs
StatePublished - Nov 1 2017

Fingerprint

Tumor Microenvironment
Cell Death
Phagocytes
Apoptosis
Immunity
Phosphatidylserines
Autoantigens
Autoimmunity
Cadaver
Immunotherapy
Synapses
Homeostasis
Cell Culture Techniques
Inflammation
Neoplasms

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Keywords

  • cell death
  • immunogenic cell death
  • phosphatidylserine
  • tolerance
  • tumor immunity

Cite this

@article{572f00293f8243099b61f0aef721aeea,
title = "Efferocytosis of dying cells differentially modulate immunological outcomes in tumor microenvironment",
abstract = "Programmed cell death (apoptosis) is an integral part of tissue homeostasis in complex organisms, allowing for tissue turnover, repair, and renewal while simultaneously inhibiting the release of self antigens and danger signals from apoptotic cell-derived constituents that can result in immune activation, inflammation, and autoimmunity. Unlike cells in culture, the physiological fate of cells that die by apoptosis in vivo is their rapid recognition and engulfment by phagocytic cells (a process called efferocytosis). To this end, apoptotic cells express specific eat-me signals, such as externalized phosphatidylserine (PS), that are recognized in a specific context by receptors to initiate signaling pathways for engulfment. The importance of carefully regulated recognition and clearance pathways is evident in the spectrum of inflammatory and autoimmune disorders caused by defects in PS receptors and signaling molecules. However, in recent years, several additional cell death pathways have emerged, including immunogenic cell death, necroptosis, pyroptosis, and netosis that interweave different cell death pathways with distinct innate and adaptive responses from classical apoptosis that can shape long-term host immunity. In this review, we discuss the role of different cell death pathways in terms of their immune potential outcomes specifically resulting in specific cell corpse/phagocyte interactions (phagocytic synapses) that impinge on host immunity, with a main emphasis on tolerance and cancer immunotherapy.",
keywords = "cell death, immunogenic cell death, phosphatidylserine, tolerance, tumor immunity",
author = "Sushil Kumar and David Calianese and Raymond Birge",
year = "2017",
month = "11",
day = "1",
doi = "10.1111/imr.12587",
language = "English (US)",
volume = "280",
pages = "149--164",
journal = "Immunological Reviews",
issn = "0105-2896",
publisher = "Wiley-Blackwell",
number = "1",

}

Efferocytosis of dying cells differentially modulate immunological outcomes in tumor microenvironment. / Kumar, Sushil; Calianese, David; Birge, Raymond.

In: Immunological Reviews, Vol. 280, No. 1, 01.11.2017, p. 149-164.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Efferocytosis of dying cells differentially modulate immunological outcomes in tumor microenvironment

AU - Kumar, Sushil

AU - Calianese, David

AU - Birge, Raymond

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Programmed cell death (apoptosis) is an integral part of tissue homeostasis in complex organisms, allowing for tissue turnover, repair, and renewal while simultaneously inhibiting the release of self antigens and danger signals from apoptotic cell-derived constituents that can result in immune activation, inflammation, and autoimmunity. Unlike cells in culture, the physiological fate of cells that die by apoptosis in vivo is their rapid recognition and engulfment by phagocytic cells (a process called efferocytosis). To this end, apoptotic cells express specific eat-me signals, such as externalized phosphatidylserine (PS), that are recognized in a specific context by receptors to initiate signaling pathways for engulfment. The importance of carefully regulated recognition and clearance pathways is evident in the spectrum of inflammatory and autoimmune disorders caused by defects in PS receptors and signaling molecules. However, in recent years, several additional cell death pathways have emerged, including immunogenic cell death, necroptosis, pyroptosis, and netosis that interweave different cell death pathways with distinct innate and adaptive responses from classical apoptosis that can shape long-term host immunity. In this review, we discuss the role of different cell death pathways in terms of their immune potential outcomes specifically resulting in specific cell corpse/phagocyte interactions (phagocytic synapses) that impinge on host immunity, with a main emphasis on tolerance and cancer immunotherapy.

AB - Programmed cell death (apoptosis) is an integral part of tissue homeostasis in complex organisms, allowing for tissue turnover, repair, and renewal while simultaneously inhibiting the release of self antigens and danger signals from apoptotic cell-derived constituents that can result in immune activation, inflammation, and autoimmunity. Unlike cells in culture, the physiological fate of cells that die by apoptosis in vivo is their rapid recognition and engulfment by phagocytic cells (a process called efferocytosis). To this end, apoptotic cells express specific eat-me signals, such as externalized phosphatidylserine (PS), that are recognized in a specific context by receptors to initiate signaling pathways for engulfment. The importance of carefully regulated recognition and clearance pathways is evident in the spectrum of inflammatory and autoimmune disorders caused by defects in PS receptors and signaling molecules. However, in recent years, several additional cell death pathways have emerged, including immunogenic cell death, necroptosis, pyroptosis, and netosis that interweave different cell death pathways with distinct innate and adaptive responses from classical apoptosis that can shape long-term host immunity. In this review, we discuss the role of different cell death pathways in terms of their immune potential outcomes specifically resulting in specific cell corpse/phagocyte interactions (phagocytic synapses) that impinge on host immunity, with a main emphasis on tolerance and cancer immunotherapy.

KW - cell death

KW - immunogenic cell death

KW - phosphatidylserine

KW - tolerance

KW - tumor immunity

UR - http://www.scopus.com/inward/record.url?scp=85031104678&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031104678&partnerID=8YFLogxK

U2 - 10.1111/imr.12587

DO - 10.1111/imr.12587

M3 - Review article

C2 - 29027226

AN - SCOPUS:85031104678

VL - 280

SP - 149

EP - 164

JO - Immunological Reviews

JF - Immunological Reviews

SN - 0105-2896

IS - 1

ER -